Avo vs OpenEvidence
OpenEvidence is free to NPI-verified physicians and funded by advertising, while Avo sells to health systems through a demo booking. OpenEvidence answers clinical questions with cited literature and guidelines, and it lists NEJM and JAMA as partners and an NCCN collaboration. The vendor states HIPAA compliance under a standard BAA and SOC 2 Type II for the Security category. Five PubMed-listed papers include comparisons with other chatbots on board-style radiology questions and AAOS guideline concordance, a secondary summary cites an NYU Langone result of 89.6% against 88.4% for UpToDate Expert AI on MedQA, and a medRxiv preprint pilot reported 31% for quick search and 39.5% for Deep Consult on subspecialty scenarios. A poster on r/Residency reported journal bias, and a poster on r/emergencymedicine reported a wrong chest x-ray and pulmonary embolism answer.
A health system's clinical standards team that wants its own guideline pathways written into the chart should drop OpenEvidence, since its pages describe literature Q&A. Avo's no-code pathways serve that team, and PubMed's AvoMD hits include no study of the product.
Decision support · Reviewed November 2, 2026

Avo
by AvoMD
Guideline-based clinical decision support and EHR chart assistants for health systems, with ambient documentation.

OpenEvidence
by OpenEvidence · founded 2022
Free physician-only literature-grounded Q&A, 1M consults/day.
When to pick each one
Avo
- Own guideline pathways embedded in the EHR chart
- Demo-based enterprise sales
OpenEvidence
- Free for NPI-verified physicians, ad-funded
- HIPAA with BAA, SOC 2 Type II
- Cited answers, NEJM and JAMA partners
Score
Each row shows points earned of points available under the published rubric.
Avo
18of 100
OpenEvidence
52of 100
| Dimension | Avo | OpenEvidence | Difference |
|---|---|---|---|
| FDA clearance | 0 / 12 | 0 / 12 | 0 |
| HIPAA / SOC2 / BAA | 6 / 10 | 0 / 10 | +6 |
| EHR integrations (count) | 1.7 / 5.6 | 0 / 5.6 | +1.7 |
| Top-3 EHR coverage (Epic / Oracle / Athena) | 3.4 / 4.8 | 0 / 4.8 | +3.4 |
| Bidirectional write-back | 0 / 1.2 | 0 / 1.2 | 0 |
| Peer-reviewed papers | 0 / 21 | 21 / 21 | -21 |
| RCT / meta-analysis / systematic review | 0 / 9 | 4.5 / 9 | -4.5 |
| Funding & adoption signal | 3 / 12 | 12 / 12 | -9 |
| Pricing transparency | 1.3 / 2.5 | 2.5 / 2.5 | -1.2 |
| Years in market | 0 / 6 | 4.2 / 6 | -4.2 |
Scroll horizontally to see every column.
Pricing
Avo
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. The pricing page returns 404; the site offers a demo booking only. |
OpenEvidence
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Plan | n/a | n/a | Free for NPI-verified physicians (ad-funded). |
Evidence
Avo
FDA decisions
No FDA decision cited in our research as of November 2, 2026.
OpenEvidence
FDA decisions
No FDA decision cited in our research as of October 20, 2026.
Peer-reviewed
5 PubMed records name OpenEvidence.
- Performance of Large Language Models on Diagnostic Radiology Board-Style Questions: A Comparative Evaluation of GPT-4o, Perplexity AI, and OpenEvidence. (opens in new tab)
- OpenEvidence. (opens in new tab)
- Concordance of ChatGPT, Gemini, Claude, and OpenEvidence with the 2024 AAOS guidelines on acute isolated meniscal pathology. (opens in new tab)
Community
20 posts sourced: 3 positive, 14 neutral, 3 negative.
Compliance and integrations
Documented from each vendor’s own pages.
| Spec | Avo | OpenEvidence |
|---|---|---|
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | Epic, athenahealth, MEDITECH | Not specified |
| Founded | n/a | 2022 |
| HQ | US | US |
Scroll horizontally to see both columns.
Common questions
Open the full decision support comparison
Differential diagnosis, treatment guidance, drug interactions, evidence-grounded Q&A. The CDS landscape ranges from the UpToDate gold standard to physician-only OpenEvidence. We compared what clinicians actually use.
